602 related articles for article (PubMed ID: 28448438)
1. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
[TBL] [Abstract][Full Text] [Related]
2. Novel iridium (III)‑derived organometallic compound for the inhibition of human platelet activation.
Shyu KG; Velusamy M; Hsia CW; Yang CH; Hsia CH; Chou DS; Jayakumar T; Sheu JR; Li JY
Int J Mol Med; 2018 May; 41(5):2589-2600. PubMed ID: 29436605
[TBL] [Abstract][Full Text] [Related]
3. Structure⁻Activity Relationship Study of Newly Synthesized Iridium-III Complexes as Potential Series for Treating Thrombotic Diseases.
Yang CH; Hsia CW; Jayakumar T; Sheu JR; Hsia CH; Khamrang T; Chen YJ; Manubolu M; Chang Y
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463221
[TBL] [Abstract][Full Text] [Related]
4. Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets.
Hsia CH; Jayakumar T; Sheu JR; Tsao SY; Velusamy M; Hsia CW; Chou DS; Chang CC; Chung CL; Khamrang T; Lin KC
Molecules; 2018 Feb; 23(2):. PubMed ID: 29470443
[TBL] [Abstract][Full Text] [Related]
5. Skepinone-L, a novel potent and highly selective inhibitor of p38 MAP kinase, effectively impairs platelet activation and thrombus formation.
Borst O; Walker B; Münzer P; Russo A; Schmid E; Faggio C; Bigalke B; Laufer S; Gawaz M; Lang F
Cell Physiol Biochem; 2013; 31(6):914-24. PubMed ID: 23817201
[TBL] [Abstract][Full Text] [Related]
6. A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies.
Hsia CH; Velusamy M; Sheu JR; Khamrang T; Jayakumar T; Lu WJ; Lin KH; Chang CC
Sci Rep; 2017 Aug; 7(1):9556. PubMed ID: 28842683
[TBL] [Abstract][Full Text] [Related]
7. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
[TBL] [Abstract][Full Text] [Related]
8. A novel antithrombotic effect of sulforaphane via activation of platelet adenylate cyclase: ex vivo and in vivo studies.
Jayakumar T; Chen WF; Lu WJ; Chou DS; Hsiao G; Hsu CY; Sheu JR; Hsieh CY
J Nutr Biochem; 2013 Jun; 24(6):1086-95. PubMed ID: 23246160
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory mechanisms of CME-1, a novel polysaccharide from the mycelia of Cordyceps sinensis, in platelet activation.
Chang Y; Hsu WH; Lu WJ; Jayakumar T; Liao JC; Lin MJ; Wang SH; Geraldine P; Lin KH; Sheu JR
Curr Pharm Biotechnol; 2015; 16(5):451-61. PubMed ID: 25751172
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo and in vivo studies of CME-1, a novel polysaccharide purified from the mycelia of Cordyceps sinensis that inhibits human platelet activation by activating adenylate cyclase/cyclic AMP.
Lu WJ; Chang NC; Jayakumar T; Liao JC; Lin MJ; Wang SH; Chou DS; Thomas PA; Sheu JR
Thromb Res; 2014 Dec; 134(6):1301-10. PubMed ID: 25294588
[TBL] [Abstract][Full Text] [Related]
11. Role for the guanine nucleotide exchange factor phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchanger 1 in platelet secretion and aggregation.
Qian F; Le Breton GC; Chen J; Deng J; Christman JW; Wu D; Ye RD
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):768-77. PubMed ID: 22207728
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.
Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH
Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases.
Lu Y; Li Q; Liu YY; Sun K; Fan JY; Wang CS; Han JY
Sci Rep; 2015 Sep; 5():13824. PubMed ID: 26345207
[TBL] [Abstract][Full Text] [Related]
15. Modulation of human platelet activation and in vivo vascular thrombosis by columbianadin: regulation by integrin α
Hou SM; Hsia CW; Tsai CL; Hsia CH; Jayakumar T; Velusamy M; Sheu JR
J Biomed Sci; 2020 May; 27(1):60. PubMed ID: 32375785
[TBL] [Abstract][Full Text] [Related]
16. Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation.
Kuliopulos A; Mohanlal R; Covic L
Thromb Haemost; 2004 Dec; 92(6):1387-93. PubMed ID: 15583748
[TBL] [Abstract][Full Text] [Related]
17. Prevention of arterial thrombosis by nobiletin: in vitro and in vivo studies.
Lu WJ; Lin KC; Liu CP; Lin CY; Wu HC; Chou DS; Geraldine P; Huang SY; Hsieh CY; Sheu JR
J Nutr Biochem; 2016 Feb; 28():1-8. PubMed ID: 26878777
[TBL] [Abstract][Full Text] [Related]
18. Suppression of Human Platelet Activation via Integrin α
Hsia CW; Tsai CL; Sheu JR; Lu WJ; Hsia CH; Velusamy M; Jayakumar T; Li JY
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717348
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo.
Lien LM; Chen ZC; Chung CL; Yen TL; Chiu HC; Chou DS; Huang SY; Sheu JR; Lu WJ; Lin KH
Eur J Pharmacol; 2014 Aug; 737():159-67. PubMed ID: 24836986
[TBL] [Abstract][Full Text] [Related]
20. Novel Therapeutic Agent against Platelet Activation In Vitro and Arterial Thrombosis In Vivo by Morin Hydrate.
Hsia CW; Wu MP; Velusamy M; Hsia CH; Chou DS; Tsai CL; Hsu CY; Jayakumar T; Chung CL; Sheu JR
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30104547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
